This document provides interim guidance for clinicians, laboratories, health workers, public health officials and
other stakeholders involved in the diagnosis and care of patients with suspected or confirmed mpox. This is an updated version of the interim guidance on Laboratory testing for the monkeypox ...
Ebola and Marburg disease outbreaks remain important public health threats. The newly published WHO Infection prevention and control guideline for Ebola and Marburg disease contains the Organization's most up to date recommendations for IPC measures to be implemented in all health facilities when caring ...
Complementary feeding, defined as the
process of providing foods in addition to
milk when breast milk or milk formula
alone are no longer adequate to meet
nutritional requirements, generally starts
at age 6 months and continues until
23 months of age, although breastfeeding
may continue beyond this perio...
Over 45.4 million infants and children under 5 years of age experience wasting each year. The risk of
wasting and nutritional oedema in infants and children, particularly in high-risk contexts where health
and socioeconomic indicators are at their poorest, is heightened by ongoing crises including climat...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this includes m...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this includes m...
In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of tocolysis as published in the WHO recommendations on interventions to improve preterm birth outco...
In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve pre...
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Janus Kinase Inhibitors/therapeutic use,
COVID-19/drug therapy,
Antiviral Agents/therapeutic use,
Ivermectin/therapeutic use,
Hydroxychloroquine/therapeutic use,
Plasma/immunology,
Fluvoxamine/therapeutic use,
Colchicine/therapeutic use,
Immunization, Passive,
Receptors, Interleukin-6/therapeutic use,
Lopinavir/therapeutic use,
Adrenal Cortex Hormones/therapeutic use
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is impor...
COVID-19/complications,
COVID-19/diagnosis,
Masks,
Global Health,
Hospitalization,
Respiration, Artificial,
Shock, Septic,
Breast Feeding,
Pregnancy,
Respiratory Distress Syndrome/etiology,
Pneumonia, Viral/etiology,
Palliative Care,
Rehabilitation,
Patient Care Management/organization & administration
